FDA NDC
Saxagliptin and Metformin
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 0378-8176
- Proprietary name
- Saxagliptin and Metformin
- Nonproprietary name
- saxagliptin and metformin
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Strength
- 2.5 mg/1
Run it in Rivvi
Which 2027 plans near you dropped or restricted saxagliptin and metformin?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.